Clinical Decision Support Systems Market is expected to reach US$ 6,689.2 million by 2028

The global clinical decision support systems market is expected to reach US$ 6,689.2 million by 2028; registering at a CAGR of 10.4% from 2022 to 2028, according to a new research study conducted by The Insight partners

Component Segment to Lead Clinical Decision Support Systems Market During 2022-2028

The report highlights the key factors driving the market and prominent players with their developments. Big data acts as a standalone factor driving the overall market growth. However, the high cost burden for implementing CDSS restricts the adoption of systems among hospitals, thereby hindering the growth of the clinical decision support systems market.

A clinical decision support system (CDSS) encompasses tools that provide patient-related data to healthcare personnel to take informed decisions at the time of care. These tools involve computerized alerts and reminders to healthcare providers and patients, clinical guidelines, condition-specific order sets, patient data reports and summaries, documentation templates, diagnostic support, and contextually relevant reference information. One of the most widely utilized source tools for collecting multidimensional data by aggregating different sources is Informatics for Integrating Biology and Bedside (i2b2) framework. Moreover, i2b2 is one of the seven centers funded by the US National Institute of Health (NIH) Roadmap for Biomedical Computing. The i2b2 tool's role is to offer clinical investigators a service-based software infrastructure capable of integrating clinical records and research data, along with wide range of search terms for querying. For example, drug prescriptions can be represented through their anatomical therapeutic chemical (ATC) drug codes in drug ontology or a subset of laboratory tests from anatomy pathology.

Clinical Decision Support Systems Market, by Region, 2022 (%)

Source: The Insight Partners Analysis

Further, visual analytics methods can be combined with evidence-based and big data-driven approaches to improve clinical performance through CDSS. Drug–drug interactions (DDIs) involving Vitamin K antagonists (VKAs) constitute an important cause of in-hospital morbidity and mortality. Therefore, the adoption of CDSS offers valuable assistance with VKA prescriptions. CDSS can identify and manage DDIs timely through pop-up alerts and improve the quality of decisions on medication prescriptions. Therefore, influx of big data technologies ultimately drives the overall CDSS market growth.

CDSS implementation has proven to substantially reduce medical errors. The Society to Improve Diagnosis in Medicine 2022 reveals estimates that major diagnostic errors are found in 10–20% of autopsies, suggesting that 40,000–80,000 patients die annually in the US due to diagnostic errors. With the implementation of CDSS for assessing disease status, clinicians can make appropriate diagnoses to approve therapy. An effective CDSS involves six levels of decision diagnosis features—alerting, interpreting, critiquing, assisting, diagnosing, and managing alerts. Automated clinical and diagnosis alerts remain an important part of error reduction strategies that prevent the high cost of healthcare delivery. Therefore, the incorporation of CDSS systems intended for diagnosis is likely to continue to catalyze the overall market growth during the forecast period.

Cerner Corporation; Medical Information Technology, Inc.; BD; Wolters Kluwer N.V.; Baxter International Inc.; Premier; Koninklijke Philips N.V.; RELX (Elsevier); PeraHealth; and Epic Systems Corporation are among the leading companies operating in the clinical decision support systems market.

The report segments the clinical decision support systems market as follows:

Based on component, the clinical decision support systems market is segmented into software, hardware, and services. The software segment held the largest market share in 2022. Based on delivery mode, the clinical decision support systems market is segregated into on-premise, cloud-based, and web-based. The on-premise segment held the largest share of the market in 2022. By application, the clinical decision support systems market is divided into drug–drug interaction, drug allergy alerts, clinical reminders, clinical guidelines, and others. The drug allergy alerts segment held the largest share of the market in 2022. Based on geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com